Jazz Pharmaceuticals PLC (JAZZ)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	3,809,840	3,569,430	2,999,690	2,284,420	2,097,480
Property, plant and equipment	US$ in thousands	165,196	223,379	251,099	127,935	131,506
Fixed asset turnover		23.06	15.98	11.95	17.86	15.95

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $3,809,840K ÷ $165,196K
= 23.06

Jazz Pharmaceuticals plc's fixed asset turnover has been fluctuating over the past five years. The ratio increased significantly from 2019 to 2020, indicating that the company generated $18.47 in revenue for every dollar invested in fixed assets in 2020. However, there was a dip in the ratio in 2021, suggesting that the company's efficiency in utilizing fixed assets to generate revenue decreased. The ratio then bounced back in 2022, reaching 16.05, but experienced a substantial improvement in 2023, where the fixed asset turnover was 22.60.

Overall, Jazz Pharmaceuticals plc's fixed asset turnover has shown variability, with the company achieving high efficiency in revenue generation from fixed assets in 2020 and 2023, but experiencing some challenges in 2021. Further analysis would be needed to understand the factors contributing to these fluctuations and assess the company's long-term operational and financial performance.